International Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled, two-stage design Phase II clinical study evaluating the efficacy and safety of XKH001 injection in participants with moderate to severe chronic obstructive pulmonary disease

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122706) titled 'A multicenter, randomized, double-blind, placebo-controlled, two-stage design Phase II clinical study evaluating the efficacy and safety of XKH001 injection in participants with moderate to severe chronic obstructive pulmonary disease' on April 16.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: China-Japan Friendship Hospital

Condition: Moderate to severe chronic obstructive pulmonary disease (COPD)

Intervention: Control group:Subcutaneous injection of placebo solution

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-04-16

Target Sample Size: Cont...